- Reduced ceramides are associated with acute rejection in liver transplant patients and skin and hepatocyte transplant mice
-
Kim N, Yoo HJ, Kang Y, Kim SJ, Yoon YI, Lee Y, Tak E, Kim JJ, Hwang S, Jung DH
- KMID: 2535632
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S116.
- doi: 10.4285/ATW2022.F-2354
We set up this study to discover novel metabolic biomarkers for acute rejection and understand the roles of ceramides on im-mune cells in acute rejection. Serum concentrations of ceramides and... -
- CITED
-
- Close
- SHARE
-
- Close
- Synergistic effect of metformin on sorafenib in in vitro study using hepatocellular carcinoma cell lines
-
Chung YG, Tak E, Hwang S, Lee JY, Kim JY, Kim YY, Song GW, Lee KJ, Kim N
- KMID: 2420606
- Ann Hepatobiliary Pancreat Surg.
- 2018 Aug;22(3):179-184.
- doi: 10.14701/ahbps.2018.22.3.179
BACKGROUNDS/AIMS: Hepatocellular carcinoma (HCC) recurrence remains a great concern following hepatic resection and liver transplantation. We investigated the metformin-induced cytotoxic effects on sorafenib in an in vitro study using HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib
-
Jung DH, Hwang S, Song GW, Ryoo BY, Kim N, Tak E, Hong HN
- KMID: 1802232
- Korean J Hepatobiliary Pancreat Surg.
- 2015 Feb;19(1):1-5.
- doi: 10.14701/kjhbps.2015.19.1.1
BACKGROUNDS/AIMS: Vitamin K may plays a role in controlling hepatocellular carcinoma (HCC) cell growth. In this study, we intended to present 5-year experience of 72 patients receiving oral vitamin K... -
- CITED
-
- Close
- SHARE
-
- Close
- Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients
-
Lim SY, Yoon YI, Kim JY, Tak E, Song GW, Kim SH, Lee SG
- KMID: 2536251
- Immune Netw.
- 2022 Jun;22(3):e24.
- doi: 10.4110/in.2022.22.e24
Coronavirus disease 2019 (COVID-19) vaccination in immunocompromised, especially transplant recipients, may induce a weaker immune response. But there are limited data on the immune response after COVID-19 vaccination in liver... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between pretransplant serum soluble programmed death protein 1 level and prognosis following liver transplantation in patients with hepatocellular carcinoma
-
Oh K, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Lee KJ, Tak E
- KMID: 2509355
- Korean J Transplant.
- 2020 Dec;34(Supple 1):S165.
- doi: 10.4285/ATW2020.PO-1105
Background: The study aimed to assess the prognostic influence of pretransplant serum soluble programmed death protein 1 (sPD-1) in patients undergoing liver transplantation (LT) for treatment of hepatocellular carcinoma (HCC). Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- High-dose tenofovir is not effective in suppressing hepatitis B virus replication in patients with hepatocellular carcinoma progression: a preliminary result
-
Hwang S, Song GW, Jung DH, Yoon YI, Yoo HJ, Tak E
- KMID: 2243025
- Korean J Hepatobiliary Pancreat Surg.
- 2016 Feb;20(1):8-11.
- doi: 10.14701/kjhbps.2016.20.1.8
BACKGROUNDS/AIMS: Nucleos(t)ide analogues (NUCs) effectively suppress hepatitis B virus (HBV) replication, but hepatocellular carcinoma (HCC) recurrence often leads to HBV replication despite NUC therapy. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Different antibody responses between liver and kidney transplant recipients elicited by third doses of COVID-19 mRNA vaccines
-
Lim SY, Yoon YI, Kim JY, Tak E, Kwon H, Shin S, Kim YH, Song GW, Kim SH, Lee SG
- KMID: 2541312
- Korean J Transplant.
- 2023 Mar;37(1):49-56.
- doi: 10.4285/kjt.22.0056
Background: Solid organ transplant recipients exhibit decreased antibody responses, mainly due to their weakened immune systems. However, data are limited on antibody responses after the primary series of coronavirus disease... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro immune cell monitoring as a guide for long-term immunosuppression in adult liver transplant recipients
-
Jwa E, Hwang S, Kwon YJ, Kim N, Song GW, Jung DH, Ahn CS, Tak E, Moon DB, Kim KH, Ha TY, Park GC, Lee SG
- KMID: 2130965
- Korean J Hepatobiliary Pancreat Surg.
- 2015 Nov;19(4):139-148.
- doi: 10.14701/kjhbps.2015.19.4.139
BACKGROUNDS/AIMS: We evaluated the clinical usability of immune cell monitoring in adult liver transplantation (LT) recipients. METHODS: This study was composed of two parts as using calcineurin phosphatase (CNP) activity assay... -
- CITED
-
- Close
- SHARE
-
- Close
- Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas
-
Ha SM, Hwang S, Park JY, Lee YJ, Kim KH, Song GW, Jung DH, Yu YS, Kim J, Lee KJ, Tak E, Park YH, Lee SG
- KMID: 2426761
- Ann Surg Treat Res.
- 2018 Dec;95(6):303-311.
- doi: 10.4174/astr.2018.95.6.303
PURPOSE: OncoHepa test is a multigene expression profile test developed for assessment of hepatocellular carcinoma (HCC) prognosis. Multiplication of α-FP, des-γ-carboxy prothrombin (DCP) and tumor volume (TV) gives the α-FP-DCP-volume... -
- CITED
-
- Close
- SHARE
-
- Close
- Methionine Adenosyltransferase 1: A Proteomic Surrogate Marker of Early Hepatocellular Carcinoma in Cirrhotic Patients
-
Lee JH, Jun MJ, Shim JH, Song GW, Tak E, Oh B, Yu E, Choi SW, An J, Lee D, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS
- KMID: 2409646
- J Liver Cancer.
- 2018 Mar;18(1):33-43.
- doi: 10.17998/jlc.18.1.33
BACKGROUND/AIMS: Because there is a lack of effective biomarkers, we aimed to discover proteomic candidate markers for hepatocellular carcinoma (HCC) in cirrhotic patients at the highest-risk of HCC, and to... -
- CITED
-
- Close
- SHARE
-
- Close
